in the Canadian rare disease treatment ecosystem. Through its strategic partnerships, Médunik Canada commercializes and develops its own orphan drugs thereby offering new therapeutic options to improve the health and quality of life of Canadians suffering from rare diseases.
10 MG TABLETS
Now available to prescribe and covered by:
*Coverage may vary depending on the plans specific criteria.